You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin therapy

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hiv Trial in Cape Town (Dolutegravir)

Recruiting
  • Hiv
  • Cape Town, Western Cape, South Africa
    Tygerberg Hospital
Oct 18, 2022

NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Kogarah, Australia
  • +29 more
Oct 20, 2022

Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +259 more
Oct 19, 2022

Hemophilia B Trial in Worldwide (FLT180a)

Terminated
Has Results
  • Hemophilia B
  • FLT180a
  • Memphis, Tennessee
  • +10 more
Nov 8, 2022

Low Back Pain Trial in Bahawalpur (Manual Therapy, Inclined Board Standing)

Recruiting
  • Low Back Pain
  • Manual Therapy
  • Inclined Board Standing
  • Bahāwalpur, Punjab, Pakistan
    Agile Institute of Rehabilitation Center
Mar 22, 2023

Burn Wound Trial in Giza (electromagnetic device)

Active, not recruiting
  • Burn Wound
  • electromagnetic device
  • Giza, Egypt
    Cairo University
Jun 1, 2022

Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome Trial in Denver, Pittsburgh (ClotTriever System,

Recruiting
  • Venous Thromboembolism
  • +2 more
  • ClotTriever System
  • Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
  • Denver, Colorado
  • +1 more
Jan 18, 2023

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8, Clinical

Active, not recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8
  • +8 more
  • Durvalumab
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 7, 2021

Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

Terminated
Has Results
  • Bladder Cancer
  • Indianapolis, Indiana
  • +2 more
Jul 7, 2022

COVID-19 Trial in Seoul (Clevudine, Placebo)

Completed
  • COVID-19
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Jul 20, 2022

Gynecologic Tumors, Epithelial Ovarian Cancer Trial in Canada, United States (PLX2853, Carboplatin)

Terminated
  • Gynecologic Neoplasms
  • Epithelial Ovarian Cancer
  • Chicago, Illinois
  • +8 more
Jul 19, 2022

MDD Trial in Fukushima (Brexpiprazole, Placebo)

Completed
  • Major Depressive Disorder
  • Fukushima, Japan
    Nanko-kokorono clinic
Jul 19, 2022

Grade II Meningioma, Intracranial Meningioma Trial in Worldwide (Clinical Observation, Radiation Therapy)

Recruiting
  • Grade II Meningioma
  • Intracranial Meningioma
  • Clinical Observation
  • Radiation Therapy
  • Birmingham, Alabama
  • +184 more
Jan 13, 2022

Erectile Dysfunction Trial in Sohag (hyperbaric oxygen therapy within hyperbaric oxygen therapy chamber.)

Active, not recruiting
  • Erectile Dysfunction
  • hyperbaric oxygen therapy within hyperbaric oxygen therapy chamber.
  • Sohag, Egypt
    Faculty of medicine sohag university
Jun 26, 2022

HIV-1-infection, HIV, PD-L1 Gene Mutation Trial in Beijing (ASC22 1mg/kg, ASC22 2.5mg/kg, Antiretroviral Therapy)

Recruiting
  • HIV-1-infection
  • +2 more
  • ASC22 1mg/kg
  • +3 more
  • Beijing, Beijing, China
    The FifthMedical Center of the General Hospital of thePeoples Li
Jun 28, 2022

Anxiety Trial in Madrid (Myofascial treatment, Sham myofascial treatment)

Completed
  • Anxiety
  • Myofascial treatment
  • Sham myofascial treatment
  • Madrid, Spain
    Pulsion Fisioterapia
Jul 31, 2022

Perihilar Cholangiocarcinoma Trial in Guangzhou (PD-1antibody plus GEMOX)

Not yet recruiting
  • Perihilar Cholangiocarcinoma
  • PD-1antibody plus GEMOX
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2022

Gastrointestinal Tumors Trial in Zhengzhou (First dose, Second dose, The third dose)

Recruiting
  • Gastrointestinal Tumors
  • First dose
  • +3 more
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Nov 22, 2023

NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

Withdrawn
  • NSCLC Stage IV
  • combination regimen tremelimumab /durvalumab
  • platinum-based chemotherapy (SoC)
  • Gauting, Germany
    Asklepios Fachkliniken München-Gauting
Sep 26, 2022

Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Radiation Therapy Boost
  • +6 more
  • Washington, District of Columbia
  • +8 more
Dec 5, 2022

Depression in Old Age, Depression, Anxiety Trial in Calgary (Problem-Solving Therapy for Older Adults)

Recruiting
  • Depression in Old Age
  • Depression, Anxiety
  • Problem-Solving Therapy for Older Adults
  • Calgary, Alberta, Canada
    Department of Psychiatry, Cumming School of Medicine, University
Feb 21, 2023

Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,

Active, not recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • Tucson, Arizona
  • +19 more
Oct 18, 2022

Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)

Not yet recruiting
  • Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
  • ARTEGENE drug product
  • Paris, France
    Department of Pediatric Immunology, Hematology and Rheumatology
Sep 26, 2022

Breast Cancer Trial in United States (Letrozole, Ribociclib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Little Rock, Arkansas
  • +12 more
Sep 24, 2022

Hirsuitism Trial in Abbottabad (IPL, Diode)

Completed
  • Hirsuitism
  • IPL
  • Diode
  • Abbottābād, Kpk, Pakistan
    Sara Ilyas
Feb 13, 2023